- Research article
- Open Access
- Open Peer Review
Detection of morphologic alterations in rectal carcinoma following preoperative radiochemotherapy based on multiphoton microscopy imaging
- Lianhuang Li†1,
- Zhifen Chen†2,
- Xingfu Wang†3,
- Hongsheng Li1,
- Weizhong Jiang2,
- Shuangmu Zhuo1,
- Guoxian Guan2Email author and
- Jianxin Chen1Email author
© Li et al.; licensee BioMed Central. 2015
- Received: 4 June 2014
- Accepted: 3 March 2015
- Published: 18 March 2015
Preoperative radiochemotherapy improves outcomes in patients with locally advanced rectal carcinoma, and has been used increasingly in patient management. However, there is a strong clinical need to assess tumor response to neoadjuvant treatment, and a non-invasive technique that allows the precise identification of morphologic changes in tumors would be of considerable clinical interest.
In this study, we used multiphoton microscopy (MPM) to detect morphologic alterations in rectal adenocarcinomas in patients treated with preoperative radiochemotherapy.
MPM was able to identify histopathologic alterations in rectal cancer following preoperative radiochemotherapy, and allowed the qualitative assessment of treatment efficacy and feasibility in relation to dose or strategy.
These findings may provide the groundwork for evaluating tumor response to neoadjuvant treatment, thus allowing the tailoring of effective treatment doses and strategies.
- Multiphoton microscopy
- Preoperative radiochemotherapy
- Two-photon excited fluorescence
- Second harmonic generation
Accumulating evidence has demonstrated that neoadjuvant treatment improves local control and survival in patients with rectal cancer, and may play an increasing role, especially in locally advanced disease [1-5]. Preoperative radiochemotherapy has thus been used increasingly in the management of this group of patients. Pathological assessment based on the histopathological investigation of resected specimens is important for estimating the prognosis and effect of radiochemotherapy [6,7]. However, pathological examination is associated with several disadvantages, such as crush artifacts, bleeding, sampling errors, and time-consuming pathological procedures [8,9]. In contrast, multiphoton microscopy (MPM), which is based on intrinsic two-photon excited fluorescence (TPEF) and second harmonic generation (SHG), offers significant advantages for imaging in thick tissue and live animals, including greater imaging penetration depth, reduced out-of-focus photobleaching and phototoxicity, and the ability to detect the cellular and subcellular microstructures of biological tissues [10-12].
This study therefore investigated the treatment-related morphologic aspects of rectal carcinomas using MPM imaging, with an emphasis on stromal alterations, changes in blood vessels and inflammatory cell infiltrate, and residual tumor cells. The study aimed to provide a detailed morphologic description of rectal carcinoma in patients treated with preoperative radiochemotherapy, and to identify patterns of morphologic alterations with prognostic significance. We also aimed to determine the efficacy of radiochemotherapy and the appropriateness of the treatment dose and strategy by monitoring theses morphological changes.
MPM imaging system
The MPM imaging system used in this study has previously been described in detail [13,14]. Briefly, MPM images were acquired using a LSM 510 META system (Zeiss, Jena, Germany) coupled to a Ti:sapphire laser (Mira 900-F, Coherent Inc., Santa Clara, CA, USA). An oil immersion objective (Plan-Apochromat 63×, N.A.1.4) was used to focus the excitation beam into samples and to collect the back-scattered TPEF/SHG signals. Two different channels were selected to obtain high-contrast images of collagen and fluorescence components, respectively. One channel corresponded to wavelengths of 387–419 nm to reveal the collagen microstructure using SHG signals, while the other channel covered wavelengths 430–716 nm to reveal the morphology of fluorescence components using TPEF signals at an excitation wavelength of 810 nm. The contrast of the SHG/TPEF images was increased by color-coding the SHG images green and the TPEF images red.
This investigation was approved by the Institutional Review Board of the Affiliated Union Hospital, Fujian Medical University and conformed with the institutional rules governing clinical investigations of human subjects in biomedical research. Prior to study participation, all patients signed an informed consent form. All patients underwent long-term preoperative radiochemotherapy (45 Gy/25 fractions followed by a 5.4 Gy boost, for a total of 50.4 Gy, and oral capecitabine 825 mg/m2 twice daily during radiotherapy). According to the Chinese guidelines for colorectal cancer treatment, radical surgery was performed about 8 weeks after the end of radiotherapy. Patients with different responses to therapy were selected, and patients who failed to respond were excluded. Tumor response to therapy was judged macroscopically in harvested specimens.
Patient information including cancer classification and clinical stage
cT2N + M0, Stage III
cT3N + M0, Stage III
cT3N + M0, Stage III
cT3N0M0, Stage II
cT3N + M0, Stage III
cT3N + M0, Stage III
cT3N + M0, Stage III
H&E-stained sections were reviewed by a certified pathologist. Images were obtained by standard bright-field light microscopy (Eclipse Ci-L, Nikon Instruments Inc., Japan) with a charge-coupled device (Nikon, DS-Fi2). Finally, the MPM and corresponding H&E-stained images (40×) were analyzed and compared by a certified pathologist.
Quantification of morphological features
Quantitative changes in fibrotic tissue, cellular architecture, and blood vessels during rectal carcinoma progression following preoperative radiochemotherapy were assessed by calculating the collagen density, nuclear area, and vessel wall thickness, respectively. For each blood vessel, three random positions were selected and the vessel wall thickness was determined as the mean thicknesses of the three positions. Collagen density was defined as the ratio of SHG to all pixels in each image. The nuclear area was calculated by measuring the area enclosed by the nuclear boundary. Values were expressed as means and standard deviations (mean ± SD). The standard deviation signified the change in nucleus size or vessel wall thicknesses, respectively.
Changes in blood vessels and inflammatory cell infiltrate
Residual tumor cells
Quantitative analysis of morphological features
Morphological features of rectal carcinoma after preoperative radiochemotherapy
Collagen density of normal submucosa
0.77 ± 0.06
Collagen density of normal serosa
0.71 ± 0.05
Collagen density of fibrosis associate with carcinoma
0.97 ± 0.03
Nuclear area (μm2) of carcinoma
83.28 ± 57.02
Vessel wall thickness (μm) of carcinoma
117.23 ± 36.46
*P < 0.0001 (collagen density between the submucosa, serosa and fibrosis), and P > 0.05 (collagen density between the submucosa and serosa).
Preoperative radiochemotherapy has been shown to be useful for reducing tumor size and increasing operability. More importantly, preoperative radiotherapy in combination with surgery has been shown to decrease the rate of local recurrence in rectal cancer patients [17-19]. Preoperative radiochemotherapy can modify the histologic appearance of rectal cancer in terms of fibrosis, colloid response (data not shown), blood vessel hyperplasia, and inflammatory reaction, and these morphologic alterations have shown clinically meaningful correlations with patient outcome [7,16]. Although these changes can be determined by histological examination of resection specimens, the procedure is troublesome and time-consuming.
Fortunately, fibrous tissues consist mainly of collagen fibers and emit strong SHG signals, whereas blood vessels, residual carcinomatous cells, and inflammatory cells contain abundant elastin and generate TPEF signals [20,21]. These signals make it possible to detect histopathologic changes using MPM. The current study employed MPM to provide a detailed morphologic description of rectal carcinomas in patients undergoing preoperative radiochemotherapy. The results demonstrated that MPM imaging was able to identify blood vessel hyperplasia and tumor regression by the disappearance of carcinoma cells and their replacement by fibrous or fibroinflammatory tissues. Furthermore, the high resolution of MPM to approximately the cellular/sub-cellular level [22,23], enables this technique to identify residual carcinomatous cells and distinguish between tumor cells and other cells with different morphologies, such as adipose cells .
There is currently no validated method for directly monitoring the efficacy of radiochemotherapy, and the appropriateness of the treatment dose and strategy. The current study showed that radiochemotherapy caused morphological changes in rectal carcinomas, including changes in nuclear shape, collagen density, and vessel wall thickness, and these changes could be identified and quantitatively described by MPM. These results suggest that MPM may be a useful tool for evaluating tumor response to neoadjuvant treatment by enabling monitoring of the morphological changes and subsequent tailoring of the effective treatment dose or strategy.
Radiochemotherapy is a standard approach in advanced solid human tumors. Tumors often develop in the mucosal layer and gradually infiltrate to the lamina propria, submucosal layer, and deeper layer of the bowel wall. The cancer is therefore most advanced in the superficial layer, and the curative effect of radiochemotherapy can be evaluated qualitatively by monitoring treatment-related morphological changes in the superficial layer. MPM has been reported to penetrate to depths of millimeters . MPM may therefore be useful for determining if radiochemotherapy has a curative effect, and if the treatment dose and strategy are appropriate regardless of cancer stage. Subsequent treatments can then be tailored to meet the specific clinical needs of different patients.
There are some drawbacks associated with this technique, and some limitations of the current study. There are three major factors limiting the in vivo application of MPM. First, the limited field of view makes examination of large areas or volumes problematic, and may lead to interobserver variability. Second, the depth of imaging is limited, though this limitation may be overcome by the continuous advancement of a gradient index lens-based MPM. Finally, the technique is expensive, though it is possible that the cost may be reduced by using a combination of fiber laser and MPM. The study limitations included the small patient number and lack of comparison of pre- and post-therapeutic samples. However, these factors do not affect the conclusion that MPM can be used to monitor tumor response to preoperative radiochemotherapy.
The importance of the impact of histopathological factors on prognosis and an awareness of the role of morphologic alterations in ensuring an accurate pathologic assessment [16,26,27] indicate the urgent need for a new, label-free, real-time, noninvasive technique for differentiating among the various morphologic alterations induced by radiochemotherapy. The results of the present study suggest that MPM might provide a real-time, label-free technique for evaluating tumor response following preoperative radiochemotherapy and for noninvasive, in vivo pathophysiological analysis. The advantages of MPM indicate that it may be useful for the in vivo assessment of treatment effect, dose, and strategy in patients with rectal carcinoma receiving preoperative radiochemotherapy.
MPM can be used to differentiate morphologic changes in rectal carcinomas in patients undergoing preoperative radiochemotherapy. The advancement of clinically miniaturized MPM and multiphoton probes to allow MPM to be combined with standard endoscopes will allow the real-time in vivo evaluation of tumor response to neoadjuvant therapy and the subsequent tailoring of effective treatment doses and strategies.
The project was supported by the Program for Changjiang Scholars and Innovative Research Team in University (Grant No. IRT1115), the National Natural Science Foundation of China (Grant No. 81271620), the Natural Science Foundation for Distinguished Young Scholars of Fujian Province (Grant No. 2014 J06016), and the Youth Scientific Research Foundation of Fujian Provincial Department of Health (2013-2-36), National Clinical Key Specialty Construction Project (General Surgery).
- Schrag D, Weiser MR, Goodman KA, Gon̈en M, Hollywood E, Cercek A, et al. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol. 2014;32:1–6.View ArticleGoogle Scholar
- Hwang MR, Park JW, Park S, Yoon H, Kim DY, Chang HJ, et al. Prognostic impact of circumferential resection margin in rectal cancer treated with preoperative chemoradiotherapy. Ann Surg Oncol. 2014;21:1345–51.View ArticlePubMedGoogle Scholar
- Wheeler JMD, Warren BF, Jones AC, Mortensen NJM. Preoperative radiotherapy for rectal cancer: implications for surgeons, pathologists and radiologists. Brit J Surg. 1999;86:1108–20.View ArticlePubMedGoogle Scholar
- Nagtegaal ID, Marijnen CAM, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJH, et al. Short term preoperative radiotherapy interferes with determination of pathological parameters in rectal cancer. J Pathol. 2002;197:20–7.View ArticlePubMedGoogle Scholar
- Hartley A, Ho KF, Mcconkey C, Geh JI. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase I/III trials. Brit J Radiol. 2005;78:934–8.View ArticlePubMedGoogle Scholar
- Thies S, Langer R. Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment. Front Oncol. 2013;3:262.View ArticlePubMedPubMed CentralGoogle Scholar
- Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Color Dis. 1997;12:19–23.View ArticleGoogle Scholar
- Ying MG, Zhuo SM, Chen G, Zhuo CH, Lu JP, Zhu WF, et al. Real-time noninvasive optical diagnosis for colorectal cancer using multiphoton microscopy. Scanning. 2012;34:181–5.View ArticlePubMedGoogle Scholar
- Wu XF, Chen G, Lu JP, Zhu WF, Qiu JT, Chen JX, et al. Label-free detection of breast masses using multiphoton microscopy. Plos One. 2013;88:e65933.View ArticleGoogle Scholar
- Chen Y, Guo HC, Gong W, Qin LY, Aleyasin H, Ratan RR, et al. Recent advances in two-photon imaging: technology developments and biomedical applications. Chin Opt Lett. 2013;11:011703.View ArticleGoogle Scholar
- Hoover EE, Squier JA. Advances in multiphoton microscopy technology. Nat Photonics. 2013;7:93–101.View ArticlePubMedPubMed CentralGoogle Scholar
- Zipfel WR, Williams RM, Christie R, Nikitin AY, Hyman BT, Webb WW. Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation. PNAS. 2003;100:7075–80.View ArticlePubMedPubMed CentralGoogle Scholar
- Chen JX, Xu J, Kang DY, Xu MF, Zhuo SM, Zhu XQ, et al. Multiphoton microscopic imaging of histological sections without hematoxylin and eosin staining differentiates carcinoma in situ lesion from normal oesophagus. Appl Phys Lett. 2013;103:183701.View ArticleGoogle Scholar
- Zhuo SM, Yan J, Chen G, Shi H, Zhu XQ, Lu JP, et al. Label-free imaging of basement membranes differentiates normal, precancerous, and cancerous colonic tissues by second-harmonic generation microscopy. Plos One. 2012;7:e38655.View ArticlePubMedPubMed CentralGoogle Scholar
- Micev M, Micev-Ćosić M, Todorović V, Krsmanović M, Krivokapić Z, Popović M, et al. Histopathology of residual rectal carcinoma following preoperative radiochemotherapy. Acta Chir Iugosl. 2004;51:99–108.View ArticlePubMedGoogle Scholar
- Shia J, Guillem JG, Moore HG, Tickoo SK, Qin J, Ruo L, et al. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol. 2004;28:215–23.View ArticlePubMedGoogle Scholar
- Nagtegaal ID, Marijnen CAM, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJH, et al. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect-a histopathological and immunohistochemical study. BMC Cancer. 2001;1:7.View ArticlePubMedPubMed CentralGoogle Scholar
- García-Aguilar J, De Anda EH, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum. 2003;46:298–304.View ArticlePubMedGoogle Scholar
- Bouzourene H, Bosman FT, Matter M, Coucke P. Predictive factors in locally advanced rectal cancer treated with preoperative hyperfractionated and accelerated radiotherapy. Hum Pathol. 2003;34:541–8.View ArticlePubMedGoogle Scholar
- Monic M. Cell and tissue autofluorescence research and diagnostic applications. Biotechnol Annu Rev. 2005;11:227–56.View ArticleGoogle Scholar
- Konig K. Multiphoton microscopy in life sciences. J Microsc. 2000;200:83–104.View ArticlePubMedGoogle Scholar
- Rivera DR, Brown CM, Quzounov DG, Webb WW, Xu C. Multifocal multiphoton endoscope. Opt Lett. 2012;37:1349–51.View ArticlePubMedGoogle Scholar
- Wang TJ, Li QY, Xiao P, Ahn J, Kim YE, Park Y, et al. Gradient index lens based combined two-photon microscopy and optical coherence tomography. Opt Express. 2014;22:12962–70.View ArticlePubMedGoogle Scholar
- Huang ZF, Zhuo SM, Chen JX, Chen R, Jiang XS. Multiphoton microscopic imaging of adipose tissue based on second-harmonic generation and two-photon excited fluorescence. Scanning. 2008;30:452–6.View ArticlePubMedGoogle Scholar
- Helmchen F, Denk W. Deep tissue two-photon microscopy. Nat Methods. 2005;2:932–40.View ArticlePubMedGoogle Scholar
- Wheeler JMD, Warren BF, Mortensen NJMCC, Ekanyaka N, Kulacoglu H, Jones AC, et al. Quantification of histologic regression of rectal cancer after irradiation. Dis Colon Rectum. 2002;45:1051–6.View ArticlePubMedGoogle Scholar
- Bozzetti F, Baratti D, Andreola S, Zucali R, Schiavo M, Spinelli P, et al. Preoperative radiation therapy for patients with T2-T3 carcinoma of the middle-to-low rectum. Cancer. 1999;86:398–404.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.